Paul Bessette

Université de Sherbrooke — Canada

Medicine · Health Sciences

28h-index4.0kcitations78works8.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(29), Endometrial and Cervical Cancer Treatments(28), Endometriosis Research and Treatment(11), Genetic factors in colorectal cancer(8), Cancer survivorship and care(6)

Publications78 total

Surgical approach, preoperative LEEP/conization and patterns of recurrence and death in low-risk cervical cancer – exploratory analysis from the CCTG CX.5/SHAPE trial
International Journal of Surgery·2025· 1 citedOpen Access
Selective support of engineered T cells using a cis-targeted interleukin-2 enhances anti-tumor activity and obviates the need for lymphodepletion
2025Open Access
ATHENA-MONO Post-Progression Survival Data Update In Patients With Newly Diagnosed Advanced Ovarian Cancer
International Journal of Gynecological Cancer·2025Open Access
Minimally invasive compared to open surgery in patients with low-risk cervical cancer following simple hysterectomy: An exploratory analysis from the Gynegologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial
International Journal of Gynecological Cancer·2024· 12 citedOpen Access
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial
Journal of Clinical Oncology·2024· 45 citedOpen Access
PR021/#195  Minimally invasive versus open surgery in patients with low risk cervical cancer who underwent simple hysterectomy; an exploratory analysis from the CCTG cx.5/shape trial cx.5/shape trial
2024
3408: Ten-year results of the PORTEC-3 trial: adjuvant therapy for women with high-risk endometrial cancer
Radiotherapy and Oncology·2024
738 Surgical approach, preoperative LEEP/cone biopsy and patterns of recurrence and death in low-risk cervical cancer – analysis of the international CCTG CX.5/SHAPE phase III trial
2024· 3 cited
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation
Modern Pathology·2024· 12 citedOpen Access
Gynecological Cancer Survivors’ Experiences of Dyspareunia and Factors Influencing Care-Seeking Behavior: A Qualitative Study
Archives of Sexual Behavior·2023· 3 cited
Selective Support of CAR-T Cell Therapies By Cis-Targeted IL-2 or IL-21 Cytokines Results in Enhanced Anti-Tumor Activity
Blood·2022· 1 cited
2022-RA-925-ESGO Development of adjuvant treatment decision support tool for endometrial cancer patients by pooled analysis of data from 2000 women included in the PORTEC-1–3 trials and a prospective cohort study
International Journal of Gynecological Cancer·2022· 1 citedOpen Access
Acceptability of multimodal pelvic floor physical therapy to treat dyspareunia after gynecological malignancies: a qualitative study of women’s views and experiences
International Urogynecology Journal·2022· 7 citedOpen Access
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)
Journal of Clinical Oncology·2022· 346 citedOpen Access
289 A QUALITATIVE STUDY OF WOMEN’S VIEWS AND EXPERIENCES OF MULTIMODAL PELVIC FLOOR PHYSIOTHERAPY FOR TREATING DYSPAREUNIA AFTER GYNECOLOGICAL CANCER: AN INSIGHT INTO THIS TREATMENT’S ACCEPTABILITY
Continence·2022Open Access
Improvements following multimodal pelvic floor physical therapy in gynecological cancer survivors suffering from pain during sexual intercourse: Results from a one-year follow-up mixed-method study
PLoS ONE·2022· 38 citedOpen Access
Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial
Clinical Oncology·2021· 4 citedOpen Access
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics·2021· 18 citedOpen Access
397 Molecular profiling of NSMP high-risk endometrial cancers of the PORTEC-3 trial – prognostic refinement and druggable targets
Endometrial cancer·2021· 9 citedOpen Access
Changes in pelvic floor morphometry and muscle function after multimodal physiotherapy for gynaecological cancer survivors suffering from dyspareunia: a prospective interventional study
Physiotherapy·2021· 11 cited
page 1 of 4Next →

Frequent Co-authors

Linda Mileshkin(12), Carien L. Creutzberg(12), Jonathan A. Ledermann(12), Stephanie M. de Boer(11), Melanie Powell(11), Remi A. Nout(11), Vincent T.H.B.M. Smit(10), Marie Plante(10), Anthony Fyles(9), Hein Putter(9), Henry C Kitchener(9), Hans W. Nijman(8), Christine Haie-Méder(8), Pearly Khaw(8), Korine Lapointe-Milot(8), Dionyssios Katsaros(7), Ina M. Jürgenliemk‐Schulz(7), Diane Provencher(7), Marie‐Pierre Cyr(7), Chantale Dumoulin(7)